Anixa Biosciences Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 4,482.9 | 3,041.4 | 988.9 | 673.0 | 46.5 | 16.4 | 3.3 | 172.4 | 202.8 | 114.9 | 121.4 | 210.2 | 33.1 | 85.2 | 49.1 | 29.2 | 55.2 | 111.1 | 13.0 | 3.8 | 186.4 | 70.7 | 65.0 | 308.7 | – | 267.9 | 0.1 | 472.1 | – | – | |
| 19.7 | 16.2 | 8.3 | 10.7 | 12.3 | 6.6 | 7.4 | 21.2 | 53.5 | 45.2 | 48.2 | 85.9 | 39.5 | 20.2 | 7.8 | 27.7 | – | – | 11.9 | 7.0 | 56.6 | 3.2 | 13.3 | 14.7 | 5.3 | 3.9 | 5.9 | 4.1 | 5.6 | 8.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 35.3 | 88.6 | 54.5 | 33.5 | 54.9 | 112.7 | 12.1 | 3.4 | – | 61.4 | 62.2 | – | – | 211.1 | 0.1 | 468.0 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 27.2 | – | – | – | – | – | – | – | – | – | – | |
| -1.0% | -3.5% | -8.0% | -9.1% | -7.1% | -2.7% | -2.7% | -2.3% | -1.2% | -3.4% | -3.0% | -2.4% | -1.3% | -2.8% | -6.7% | -2.5% | -6.1% | -7.4% | -5.0% | 3.7% | -6.3% | -14.9% | -6.0% | -6.4% | -13.3% | -3.6% | -3.8% | -6.3% | -6.6% | -5.4% | |
| Margins | ||||||||||||||||||||||||||||||
| 200.0% | 400.0% | 400.0% | 400.0% | 68.5% | 58.7% | 63.9% | 28.0% | 64.4% | -63.6% | 69.2% | 67.1% | 95.4% | 93.8% | 88.7% | 96.6% | 100.0% | 18.6% | 45.8% | 60.6% | 27.5% | 71.2% | 1.7% | 33.5% | – | 24.8% | 100.0% | 23.3% | – | – | |
| -6,000.0% | -6,300.0% | -7,100.0% | -8,200.0% | -345.5% | -213.2% | -63.8% | -1,277.2% | -680.5% | -1,015.4% | -1,499.6% | -1,128.1% | -290.3% | -693.3% | -718.3% | -501.2% | -439.8% | -2,036.2% | -137.5% | -10.2% | -1,503.0% | -1,676.0% | -1,232.0% | -4,756.0% | – | -2,565.6% | -0.6% | -5,243.3% | – | – | |
| -5,400.0% | -5,800.0% | -7,100.0% | -8,500.0% | -337.2% | -211.3% | -63.3% | -1,275.2% | -679.7% | -1,012.1% | -1,494.3% | -1,121.1% | -282.2% | -1,561.8% | -708.3% | -735.5% | -452.4% | -2,592.3% | -261.9% | -14.9% | -1,672.1% | -1,381.8% | -1,258.1% | -4,658.8% | – | -2,528.6% | -0.6% | -4,671.9% | – | – | |
| -4,600.0% | -10,600.0% | -7,900.0% | -6,100.0% | -330.9% | -43.4% | -9.1% | -392.9% | -246.9% | -392.0% | -365.3% | -495.1% | -44.4% | -237.1% | -329.5% | -72.3% | -334.1% | -819.5% | -65.1% | 14.1% | -1,176.1% | -1,055.7% | -387.6% | -1,966.8% | – | -964.5% | -0.3% | -2,956.7% | – | – | |
| Returns | ||||||||||||||||||||||||||||||
| -23.7% | -30.9% | -59.7% | -134.9% | -89.3% | -85.7% | -141.8% | -156.6% | -179.4% | -398.1% | -593.0% | -458.2% | -336.5% | -370.4% | -112.6% | -697.3% | – | – | -239.6% | -27.3% | -508.0% | -63.2% | -257.5% | -222.5% | -115.7% | -36.5% | -46.8% | -40.3% | -62.8% | -72.1% | |
| -21.9% | -29.0% | -53.4% | -104.9% | -72.0% | -54.4% | -120.3% | -133.6% | -145.1% | -303.6% | -407.9% | -291.9% | -77.6% | -167.4% | -51.5% | -85.3% | -75.1% | -185.3% | -106.1% | -14.8% | -89.1% | -56.8% | -217.0% | -185.1% | -107.2% | -35.7% | -44.7% | -38.4% | -58.1% | -68.0% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | 4.5 | 3.5 | 3.9 | 4.2 | -0.3 | 0.6 | -3.4 | -4.4 | – | -3.3 | -3.1 | – | -6.4 | -29 | -12 | -0.9 | -1.2 | -1.2 | |
| 92.3% | 94.0% | 89.5% | 77.8% | 80.6% | 63.5% | 84.8% | 85.3% | 80.9% | 76.3% | 68.8% | 63.7% | 23.1% | 45.2% | 45.7% | 12.2% | -21.1% | -61.0% | 44.3% | 54.1% | 17.5% | 89.9% | 84.3% | 83.2% | 92.7% | 97.7% | 95.5% | 95.4% | 92.6% | 94.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 2.9 | 1.1 | 1.1 | 4.7 | – | – | 0.0 | 0.0 | – | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||
| -2.17 | -2.29 | -2.69 | -3.16 | -1.81 | -1.26 | -1.10 | -0.94 | -0.92 | -1.14 | -1.81 | -1.20 | -1.02 | -2.70 | -0.79 | -1.01 | -0.53 | -1.17 | -1.00 | -0.14 | -0.57 | -0.41 | -0.79 | -0.59 | -0.46 | -0.45 | -0.45 | -0.32 | -0.39 | -0.34 | |
| 0.04 | 0.04 | 0.04 | 0.04 | 0.54 | 0.60 | 1.73 | 0.07 | 0.14 | 0.11 | 0.12 | 0.11 | 0.36 | 0.17 | 0.11 | 0.14 | 0.12 | 0.04 | 0.38 | 0.96 | 0.03 | 0.03 | 0.06 | 0.01 | 0.00 | 0.02 | 81.29 | 0.01 | 0.00 | 0.00 | |
| 9.15 | 7.42 | 4.51 | 2.34 | 2.03 | 1.47 | 0.77 | 0.60 | 0.51 | 0.29 | 0.31 | 0.26 | 0.30 | 0.73 | 0.70 | 0.14 | -0.15 | -0.38 | 0.42 | 0.53 | 0.11 | 0.65 | 0.31 | 0.26 | 0.39 | 1.24 | 0.96 | 0.79 | 0.63 | 0.47 | |
| -1.85 | -4.18 | -3.00 | -2.27 | -1.78 | -0.26 | -0.16 | -0.29 | -0.33 | -0.44 | -0.44 | -0.53 | -0.16 | -0.41 | -0.37 | -0.10 | -0.39 | -0.37 | -0.25 | 0.14 | -0.40 | -0.31 | -0.24 | -0.25 | -0.28 | -0.17 | -0.21 | -0.20 | -0.23 | -0.22 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.